Annual SGA
$9.62 M
+$365.00 K+3.94%
December 31, 2023
Summary
- As of March 10, 2025, INMB annual SGA is $9.62 million, with the most recent change of +$365.00 thousand (+3.94%) on December 31, 2023.
- During the last 3 years, INMB annual SGA has risen by +$3.30 million (+52.24%).
- INMB annual SGA is now at all-time high.
Performance
INMB SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$2.22 M
-$593.00 K-21.09%
September 30, 2024
Summary
- As of March 10, 2025, INMB quarterly SGA is $2.22 million, with the most recent change of -$593.00 thousand (-21.09%) on September 30, 2024.
- Over the past year, INMB quarterly SGA has dropped by -$593.00 thousand (-21.09%).
- INMB quarterly SGA is now -62.30% below its all-time high of $5.89 million, reached on June 30, 2018.
Performance
INMB Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$548.75 M
-$41.27 M-8.13%
September 30, 2024
Summary
- As of March 10, 2025, INMB TTM SGA is -$548.75 million, with the most recent change of -$41.27 million (-8.13%) on September 30, 2024.
- Over the past year, INMB TTM SGA has dropped by -$558.88 million (-5513.85%).
- INMB TTM SGA is now -47295.75% below its all-time high of -$1.16 million.
Performance
INMB TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
INMB Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.9% | -21.1% | -5513.9% |
| 3 y3 years | +52.2% | -21.1% | -5513.9% |
| 5 y5 years | +5.9% | -21.1% | -5513.9% |
INMB Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +9.5% | -21.1% | +4.4% | -174.0% | at low |
| 5 y | 5-year | at high | +60.0% | -21.1% | +84.3% | -666.1% | at low |
| alltime | all time | at high | +7537.3% | -62.3% | +1287.7% | <-9999.0% | at low |
INmune Bio Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $2.22 M(-21.1%) | $9.77 M(-3.6%) |
| Jun 2024 | - | $2.81 M(+20.3%) | $10.14 M(+5.2%) |
| Mar 2024 | - | $2.34 M(-2.6%) | $9.63 M(+0.1%) |
| Dec 2023 | $9.62 M(+3.9%) | $2.40 M(-7.2%) | $9.62 M(+0.7%) |
| Sep 2023 | - | $2.59 M(+12.0%) | $9.55 M(+2.2%) |
| Jun 2023 | - | $2.31 M(-0.8%) | $9.35 M(+1.0%) |
| Mar 2023 | - | $2.33 M(-0.0%) | $9.25 M(-0.0%) |
| Dec 2022 | $9.26 M(+5.3%) | $2.33 M(-2.2%) | $9.26 M(+2.3%) |
| Sep 2022 | - | $2.38 M(+7.5%) | $9.05 M(-1.4%) |
| Jun 2022 | - | $2.21 M(-5.0%) | $9.19 M(+1.4%) |
| Mar 2022 | - | $2.33 M(+9.7%) | $9.06 M(+3.1%) |
| Dec 2021 | $8.79 M(+39.1%) | $2.13 M(-15.5%) | $8.79 M(+9.5%) |
| Sep 2021 | - | $2.52 M(+20.3%) | $8.03 M(+0.7%) |
| Jun 2021 | - | $2.09 M(+1.4%) | $7.97 M(+12.5%) |
| Mar 2021 | - | $2.06 M(+51.4%) | $7.08 M(+12.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $6.32 M(+5.1%) | $1.36 M(-44.6%) | $6.32 M(-1.6%) |
| Sep 2020 | - | $2.46 M(+104.1%) | $6.43 M(+9.2%) |
| Jun 2020 | - | $1.20 M(-7.3%) | $5.88 M(-2.2%) |
| Mar 2020 | - | $1.30 M(-11.4%) | $6.02 M(+0.0%) |
| Dec 2019 | $6.02 M(-33.8%) | $1.47 M(-23.5%) | $6.02 M(+10.6%) |
| Sep 2019 | - | $1.92 M(+43.5%) | $5.44 M(+23.4%) |
| Jun 2019 | - | $1.34 M(+2.9%) | $4.41 M(-50.8%) |
| Mar 2019 | - | $1.30 M(+46.3%) | $8.96 M(-13.9%) |
| Dec 2018 | $9.09 M(+1563.6%) | $887.70 K(+0.3%) | $10.40 M(+7.5%) |
| Sep 2018 | - | $885.20 K(-85.0%) | $9.67 M(+6.9%) |
| Jun 2018 | - | $5.89 M(+114.6%) | $9.05 M(+186.1%) |
| Mar 2018 | - | $2.74 M(+1615.1%) | $3.16 M(+651.2%) |
| Dec 2017 | $546.10 K(+333.4%) | $159.90 K(-38.8%) | $421.10 K(+61.2%) |
| Sep 2017 | - | $261.20 K | $261.20 K |
| Dec 2016 | $126.00 K | - | - |
FAQ
- What is INmune Bio annual SGA?
- What is the all time high annual SGA for INmune Bio?
- What is INmune Bio annual SGA year-on-year change?
- What is INmune Bio quarterly SGA?
- What is the all time high quarterly SGA for INmune Bio?
- What is INmune Bio quarterly SGA year-on-year change?
- What is INmune Bio TTM SGA?
- What is the all time high TTM SGA for INmune Bio?
- What is INmune Bio TTM SGA year-on-year change?
What is INmune Bio annual SGA?
The current annual SGA of INMB is $9.62 M
What is the all time high annual SGA for INmune Bio?
INmune Bio all-time high annual SGA is $9.62 M
What is INmune Bio annual SGA year-on-year change?
Over the past year, INMB annual SGA has changed by +$365.00 K (+3.94%)
What is INmune Bio quarterly SGA?
The current quarterly SGA of INMB is $2.22 M
What is the all time high quarterly SGA for INmune Bio?
INmune Bio all-time high quarterly SGA is $5.89 M
What is INmune Bio quarterly SGA year-on-year change?
Over the past year, INMB quarterly SGA has changed by -$593.00 K (-21.09%)
What is INmune Bio TTM SGA?
The current TTM SGA of INMB is -$548.75 M
What is the all time high TTM SGA for INmune Bio?
INmune Bio all-time high TTM SGA is -$1.16 M
What is INmune Bio TTM SGA year-on-year change?
Over the past year, INMB TTM SGA has changed by -$558.88 M (-5513.85%)